Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Clinical trial NCT00093002 · COMPLETED
Trial details
- NCT number
- NCT00093002
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.